OACC
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary ShareKey Statistics
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) focused on identifying and merging with transformative businesses in the life sciences sector, including healthcare technology, therapeutics, and medical devices. Leveraging the expertise of its experienced management team, OACC aims to drive innovation and generate value through strategic acquisitions and partnerships. With a disciplined investment strategy that emphasizes rigorous due diligence, OACC is well-positioned to capitalize on emerging opportunities within the dynamic life sciences market, thereby enhancing shareholder value amidst evolving industry trends.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | 1.34 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.78M |
| Float | $18.46M |
| % Insiders | 0.00% |
| % Institutions | 90.68% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OACC and any ticker you trade — then tracks every position and per-strategy win rate.